Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
Stimulant-induced delirium including amphetamines, methamphetamine and methcathinone is characterized by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or withdrawal or during the use of stimulants. The amount and duration of stimulant use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioral and neurodevelopmental disorders.
ICD-11 diagnostic criteria
- zaburzenia świadomości
- związek czasowy z używaniem stymulantów
How to recognise
In the ICD-11 framework, the core symptoms taken into account when recognising Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone are:
- dezorientacja
Differential diagnosis
When diagnosing Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone, the following ICD-11 disorders should be considered in the differential diagnosis:
- Majaczenie związane z używaniem kokainy (6C45.5)
- Majaczenie związane z używaniem syntetycznych katynonów (6C47.5)
- Zaburzenia spowodowane używaniem kofeiny (6C48)
Frequently asked questions
How is Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone diagnosed according to ICD-11?
According to ICD-11, the diagnostic criteria for Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone (6C46.5) include: zaburzenia świadomości; związek czasowy z używaniem stymulantów.
What disorders are in the differential diagnosis of Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone?
The differential diagnosis of Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone (6C46.5) includes: Majaczenie związane z używaniem kokainy (6C45.5), Majaczenie związane z używaniem syntetycznych katynonów (6C47.5), Zaburzenia spowodowane używaniem kofeiny (6C48).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6C46.5 – WHO ICD-11
Notes
Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną
Open in interactive browser →